![Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors | BMC Genomics | Full Text Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors | BMC Genomics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12864-019-6344-3/MediaObjects/12864_2019_6344_Fig3_HTML.png)
Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors | BMC Genomics | Full Text
![Cancers | Free Full-Text | Mouse-Derived Isograft (MDI) In Vivo Tumor Models I. Spontaneous sMDI Models: Characterization and Cancer Therapeutic Approaches | HTML Cancers | Free Full-Text | Mouse-Derived Isograft (MDI) In Vivo Tumor Models I. Spontaneous sMDI Models: Characterization and Cancer Therapeutic Approaches | HTML](https://www.mdpi.com/cancers/cancers-11-00244/article_deploy/html/images/cancers-11-00244-g001.png)
Cancers | Free Full-Text | Mouse-Derived Isograft (MDI) In Vivo Tumor Models I. Spontaneous sMDI Models: Characterization and Cancer Therapeutic Approaches | HTML
![Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies - Annals of Oncology Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a8310041-4ea1-4d5b-98d4-2c127214bc45/gr1_lrg.jpg)
Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies - Annals of Oncology
Murine models for immunotherapy studies of HCC. (A) Syngeneic mouse... | Download Scientific Diagram
![Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models | Scientific Reports Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-80216-1/MediaObjects/41598_2020_80216_Fig2_HTML.png)
Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models | Scientific Reports
![Frontiers | Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma Frontiers | Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma](https://www.frontiersin.org/files/MyHome%20Article%20Library/499929/499929_Thumb_400.jpg)
Frontiers | Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma
![Using Syngeneic Models for the Discovery of Combination Therapy Targets & Predictive Biomarkers of Immunotherapy Efficacy - Drug Discovery World (DDW) Using Syngeneic Models for the Discovery of Combination Therapy Targets & Predictive Biomarkers of Immunotherapy Efficacy - Drug Discovery World (DDW)](https://www.ddw-online.com/media/32/105-figure-1.jpg)
Using Syngeneic Models for the Discovery of Combination Therapy Targets & Predictive Biomarkers of Immunotherapy Efficacy - Drug Discovery World (DDW)
![IJMS | Free Full-Text | Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer | HTML IJMS | Free Full-Text | Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer | HTML](https://www.mdpi.com/ijms/ijms-23-09195/article_deploy/html/images/ijms-23-09195-g001.png)
IJMS | Free Full-Text | Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer | HTML
![Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models | Scientific Reports Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-80216-1/MediaObjects/41598_2020_80216_Fig5_HTML.png)
Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models | Scientific Reports
![The role of mouse tumour models in the discovery and development of anticancer drugs | British Journal of Cancer The role of mouse tumour models in the discovery and development of anticancer drugs | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-019-0495-5/MediaObjects/41416_2019_495_Fig1_HTML.png)
The role of mouse tumour models in the discovery and development of anticancer drugs | British Journal of Cancer
![Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology | SpringerLink Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10147-019-01520-z/MediaObjects/10147_2019_1520_Fig1_HTML.png)